Evaluation of Evidence for Pathogenicity Demonstrates That BLK, KLF11, and PAX4 Should Not Be Included in Diagnostic Testing for MODY
© 2022 by the American Diabetes Association..
Maturity-onset diabetes of the young (MODY) is an autosomal dominant form of monogenic diabetes, reported to be caused by variants in 16 genes. Concern has been raised about whether variants in BLK (MODY11), KLF11 (MODY7), and PAX4 (MODY9) cause MODY. We examined variant-level genetic evidence (cosegregation with diabetes and frequency in population) for published putative pathogenic variants in these genes and used burden testing to test gene-level evidence in a MODY cohort (n = 1,227) compared with a control population (UK Biobank [n = 185,898]). For comparison we analyzed well-established causes of MODY, HNF1A, and HNF4A. The published variants in BLK, KLF11, and PAX4 showed poor cosegregation with diabetes (combined logarithm of the odds [LOD] scores ≤1.2), compared with HNF1A and HNF4A (LOD scores >9), and are all too common to cause MODY (minor allele frequency >4.95 × 10-5). Ultra-rare missense and protein-truncating variants (PTV) were not enriched in a MODY cohort compared with the UK Biobank population (PTV P > 0.05, missense P > 0.1 for all three genes) while HNF1A and HNF4A were enriched (P < 10-6). Findings of sensitivity analyses with different population cohorts supported our results. Variant and gene-level genetic evidence does not support BLK, KLF11, or PAX4 as a cause of MODY. They should not be included in MODY diagnostic genetic testing.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:71 |
---|---|
Enthalten in: |
Diabetes - 71(2022), 5 vom: 01. Mai, Seite 1128-1136 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Laver, Thomas W [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 22.04.2022 Date Revised 14.02.2024 published: Print figshare: 10.2337/figshare.19099838 Citation Status MEDLINE |
---|
doi: |
10.2337/db21-0844 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM336419252 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM336419252 | ||
003 | DE-627 | ||
005 | 20240214232421.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2337/db21-0844 |2 doi | |
028 | 5 | 2 | |a pubmed24n1292.xml |
035 | |a (DE-627)NLM336419252 | ||
035 | |a (NLM)35108381 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Laver, Thomas W |e verfasserin |4 aut | |
245 | 1 | 0 | |a Evaluation of Evidence for Pathogenicity Demonstrates That BLK, KLF11, and PAX4 Should Not Be Included in Diagnostic Testing for MODY |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.04.2022 | ||
500 | |a Date Revised 14.02.2024 | ||
500 | |a published: Print | ||
500 | |a figshare: 10.2337/figshare.19099838 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022 by the American Diabetes Association. | ||
520 | |a Maturity-onset diabetes of the young (MODY) is an autosomal dominant form of monogenic diabetes, reported to be caused by variants in 16 genes. Concern has been raised about whether variants in BLK (MODY11), KLF11 (MODY7), and PAX4 (MODY9) cause MODY. We examined variant-level genetic evidence (cosegregation with diabetes and frequency in population) for published putative pathogenic variants in these genes and used burden testing to test gene-level evidence in a MODY cohort (n = 1,227) compared with a control population (UK Biobank [n = 185,898]). For comparison we analyzed well-established causes of MODY, HNF1A, and HNF4A. The published variants in BLK, KLF11, and PAX4 showed poor cosegregation with diabetes (combined logarithm of the odds [LOD] scores ≤1.2), compared with HNF1A and HNF4A (LOD scores >9), and are all too common to cause MODY (minor allele frequency >4.95 × 10-5). Ultra-rare missense and protein-truncating variants (PTV) were not enriched in a MODY cohort compared with the UK Biobank population (PTV P > 0.05, missense P > 0.1 for all three genes) while HNF1A and HNF4A were enriched (P < 10-6). Findings of sensitivity analyses with different population cohorts supported our results. Variant and gene-level genetic evidence does not support BLK, KLF11, or PAX4 as a cause of MODY. They should not be included in MODY diagnostic genetic testing | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Apoptosis Regulatory Proteins |2 NLM | |
650 | 7 | |a Hepatocyte Nuclear Factor 1-alpha |2 NLM | |
650 | 7 | |a Homeodomain Proteins |2 NLM | |
650 | 7 | |a KLF11 protein, human |2 NLM | |
650 | 7 | |a PAX4 protein, human |2 NLM | |
650 | 7 | |a Paired Box Transcription Factors |2 NLM | |
650 | 7 | |a Repressor Proteins |2 NLM | |
650 | 7 | |a BLK protein, human |2 NLM | |
650 | 7 | |a EC 2.7.10.2 |2 NLM | |
650 | 7 | |a src-Family Kinases |2 NLM | |
650 | 7 | |a EC 2.7.10.2 |2 NLM | |
700 | 1 | |a Wakeling, Matthew N |e verfasserin |4 aut | |
700 | 1 | |a Knox, Olivia |e verfasserin |4 aut | |
700 | 1 | |a Colclough, Kevin |e verfasserin |4 aut | |
700 | 1 | |a Wright, Caroline F |e verfasserin |4 aut | |
700 | 1 | |a Ellard, Sian |e verfasserin |4 aut | |
700 | 1 | |a Hattersley, Andrew T |e verfasserin |4 aut | |
700 | 1 | |a Weedon, Michael N |e verfasserin |4 aut | |
700 | 1 | |a Patel, Kashyap A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diabetes |d 1952 |g 71(2022), 5 vom: 01. Mai, Seite 1128-1136 |w (DE-627)NLM000060011 |x 1939-327X |7 nnns |
773 | 1 | 8 | |g volume:71 |g year:2022 |g number:5 |g day:01 |g month:05 |g pages:1128-1136 |
856 | 4 | 0 | |u http://dx.doi.org/10.2337/db21-0844 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 71 |j 2022 |e 5 |b 01 |c 05 |h 1128-1136 |